US Patent Issued to Universiteit Antwerpen on Sept. 8 for "Mucins and isoforms thereof in diseases characterized by barrier dysfunction" (Belgian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,407, issued on Sept. 8, was assigned to Universiteit Antwerpen (Antwerp, Belgium).

"Mucins and isoforms thereof in diseases characterized by barrier dysfunction" was invented by Annemieke Smet (Sint-Niklaas, Belgium), Benedicte De Winter ('s-Gravenwezel, Belgium) and Tom Breugelmans (Turnhout, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "Mucins and isoforms thereof are provided herein for use in the diagnosis, monitoring, prevention, and/or treatment of a disease characterized by barrier dysfunction, such as, but not limited to a gastrointestinal disorder (e.g. Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), cancer, gastr...